---
title: "ABK Biomedical finished enrolling in ROUTE90 trial for liver cancer. Final patient treated in FDA study for HCC. 104 characters."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276751616.md"
description: "The last participant has received treatment in a Food and Drug Administration Investigational Device Exemption (FDA IDE) study investigating the efficacy of Eye90 microspheres® in managing unresectable Hepatocellular Carcinoma (HCC). This significant development occurred in Halifax, NS on February 24, 2026. ABK Biomedical, Inc., a pioneering medical device business committed to advancing the treatment landscape, led the study."
datetime: "2026-02-24T14:16:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276751616.md)
  - [en](https://longbridge.com/en/news/276751616.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276751616.md)
generator: "portal-rs"
---

# ABK Biomedical finished enrolling in ROUTE90 trial for liver cancer. Final patient treated in FDA study for HCC. 104 characters.

The last participant has received treatment in a Food and Drug Administration Investigational Device Exemption (FDA IDE) study investigating the efficacy of Eye90 microspheres® in managing unresectable Hepatocellular Carcinoma (HCC). This significant development occurred in Halifax, NS on February 24, 2026. ABK Biomedical, Inc., a pioneering medical device business committed to advancing the treatment landscape, led the study.

### Related Stocks

- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [CLSDQ.US](https://longbridge.com/en/quote/CLSDQ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [Cramer's lightning round: Nuvation Bio 'is a pure spec'](https://longbridge.com/en/news/297966838.md)
- [Legal & General Group Plc Takes $1.16 Million Position in Ocular Therapeutix, Inc. $OCUL](https://longbridge.com/en/news/298278897.md)
- [Does IMAAVY’s Approval and Ongoing Talc Verdict Meaningfully Shift the Bull Case for Johnson & Johnson (JNJ)?](https://longbridge.com/en/news/298140186.md)
- [Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case.](https://longbridge.com/en/news/298119331.md)
- [Empowered Funds LLC Sells 24,477 Shares of AbbVie Inc. $ABBV](https://longbridge.com/en/news/298181607.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**